- PolarSeal Appoints Chris Locke New CTO
- Nectero Medical Secures Category III CPT Codes for Investigational Therapy to Treat Small- to Medium-Sized AAAs
- Medtronic Announces MiniMed as Name for Planned New Diabetes Company
- How Individual Coverage Health Reimbursement Arrangements Are Changing Health Benefits
- Frederick Beddingfield III, M.D., Ph.D. Joins Neurodon Board of Directors
Medical Device News Magazine
Medical Device News Magazine delivers current information regarding the medical device and diagnostic industry tailored to medical professionals, industry leaders, and investors. This digital publication offers breaking news on medical devices, including clinical trials, updates, investor insights, industry developments, and more. Besides website publications, news is shared across multiple platforms, including social media, ensuring widespread distribution of industry updates and expert insights.
Medical Device News
Nectero Medical Secures Category III CPT Codes for Investigational Therapy to Treat Small- to Medium-Sized AAAs
This designation represents a key milestone toward future reimbursement and broader clinical adoption.
Medtronic Announces MiniMed as Name for Planned New Diabetes Company
The name honors the company’s roots, reflecting its original name prior to its acquisition by Medtronic in 2001, and a deep 40-year history of being at the forefront of transforming diabetes care around the world.
Project Uses AI to Develop an Innovative System for Diagnosing and Rehabilitating Joint Conditions
This tool offers comprehensive monitoring of musculoskeletal disease progression in each patient, enabling more effective medical and rehabilitation interventions while reducing economic impact. The KINESSENSOR project, funded by IVACE+i and the ERDF, facilitates personalized treatments, thereby improving their effectiveness.
Industry Expert Byline
Precision Medicine – Closing the Loop: Why a Test Alone Isn’t Enough | By Dr Tom Stubbs – CEO Hurdle
‘Closing the Loop: Why a Test Alone isn’t enough’ is about how diagnostics is the gateway to precision Medicine. But what happens before and after the test? In a healthcare system made up of multiple initiatives and institutions, working in siloes, even the most advanced insights can fail to reach their potential.
This article includes a Real-World Example: At-Home Cardiovascular Risk Screening. Take cardiovascular disease a leading cause of death in both the US and UK. In traditional systems, screening often relies on in-person visits that many people never make, particularly amongst the most socially deprived groups.
FDA
TYBR Health Announces FDA 510(k) Clearance for B3 GEL™ System
A flowable bio-gel to protect healing tissue and preserve function.
Market Reports
IV Therapy & Vein Access: Innovations Driving the Global Healthcare Market
“Intravenous (IV) therapy and vein access play a crucial role in delivering medications, fluids and nutrients directly into the bloodstream. The global market for these technologies is growing due to increasing healthcare needs, advancements in medical devices and rising demand for efficient patient care.”
Clinical Trials
PhotoniCare’s OtoSight Demonstrates More Accurate Diagnosis and a 50 Percent Reduction in Antibiotic Usage for Pediatric Ear Infections in Large Randomized Controlled Trial
The results of the study, Otitis Treatment with OtoSight™ – Modification of Antibiotic Treatment Intervention in Children (OTO-MATIC), have been published via open access in the International Journal of Pediatric Otorhinolaryngology.
Schreiner MediPharm Introduces Smart Syringe Box for Tracking in Clinical Trials
Solution provides intelligent packaging for precise therapy monitoring of syringes used in clinical trials.
Mergers / Acquisitions
Sun Nuclear Acquires Oncospace, AI-Focused Radiation Oncology Software Provider
This strategic move underscores the Sun Nuclear commitment to leverage cutting-edge technology to improve treatment outcomes on behalf of their customers.
Biotech
Pimicotinib Demonstrates Best-in-Class Potential with Significant Efficacy and Clinically Meaningful Improvements in Patients with Tenosynovial Giant Cell Tumor
Merck KGaA, Darmstadt, Germany, today announced the presentation of detailed positive results from Part 1 of the global Phase 3 MANEUVER trial evaluating pimicotinib in TGCT.
New Drug Approval for In-House Developed Anti-Insomnia Drug DAYVIGO (Lemborexant) in China
Eisai plans to launch this medicine in China in the second quarter of fiscal year 2025.
Caliway Biopharmaceuticals Announces Successful EOP2 Meeting with the FDA for CBL-514 in Reduction of Abdominal Subcutaneous Fat
Caliway has completed the End-of-Phase 2 (EOP2) meeting with the U.S. FDA for CBL-514, the world’s first investigational drug for large-area subcutaneous fat reduction developed under the 505(b)(1) regulatory pathway.
Funding
Ceryx Medical Secures $15 Million | To Advance Groundbreaking Heart Failure Technology
Funding to drive development of permanent bioelectronic pacemaker following promising clinical data.
Hospitals In the News
Reveal 35C to be Installed at Canossa Hospital in Hong Kong | KA Imaging and Canossa Hospital Sign Memorandum of Understanding for Dual-Energy X-ray Technology Deployment
The agreement was formalized during a signing ceremony at the 5th Asia Summit on Global Health, with Dr. Karim S. Karim, Chief Technology Officer of KA Imaging, and Dr. Andrew Hui, Chief Operating Officer of Canossa Hospital, as signatories.
S.L. Raheja Hospital, Mumbai Completes 50 TAVI Procedures, Showcasing Excellence Minimally Invasive Heart Solutions
This milestone puts S.L. Raheja Hospital, Mahim, at the forefront of cardiac care in Mumbai, with one of Mumbai’s most advanced Structural Heart Programs.
Imaging
Isotopia and Cardirad Announce Launch of Isoprotrace ® in Sweden and Denmark, Expanding Access to Advanced Prostate Cancer Imaging
The introduction of Isoprotrace® into these Nordic markets marks a significant step forward in expanding access to precision diagnostic tools for prostate cancer.
Hyperfine Announces FDA Clearance of Optive AI™ Software, Introducing the Most Substantial Image Quality Improvement Ever for the Swoop® System
Latest Swoop® System software delivers a substantial leap in image quality for AI-powered portable MR brain imaging.
Executives on the Move
PolarSeal Appoints Chris Locke New CTO
Chris Locke brings over two decades of global experience in medical device R&D, technology strategy, and organisational transformation.
Frederick Beddingfield III, M.D., Ph.D. Joins Neurodon Board of Directors
Dr. Beddingfield is a 22-year veteran of the biopharma industry
SynerFuse® Announces Chief Technology Officer | Michael Park, M.D., Ph.D.
Dr. Park is a former principal investigator for the SynerFuse® proof-of-concept study and primary inventor of SynerFuse® technology.
The Business of Healthcare
Careers in Healthcare
Nurses Corner
How Individual Coverage Health Reimbursement Arrangements Are Changing Health Benefits
Many employers researching innovative ways to redesign their benefits programs are now looking into ADP’s plans and similar offerings to see how they can deliver a personalized experience without sacrificing business stability.
The Growing Demand for Compassionate Counselors in Underserved Communities
Mental health issues affect people in every corner of the country, but underserved communities continue to face the greatest challenges.
Vitalacy Debuts Gen5 Hand Hygiene Wearable with Improved Features
The Gen5 Wearable can be worn as a clip on the torso or a band on the wrist of a care provider.